Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter van Harten

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
CNS Drugs|February 11, 2018
Tardive Dyskinesia Associated with Atypical Antipsychotics: Prevalence, Mechanisms and Management StrategiesKatharina Stegmayer, Sebastian Walther, Peter van Harten
Handbook of Clinical Neurology|November 16, 2019
The psychopharmacology of catatonia, neuroleptic malignant syndrome, akathisia, tardive dyskinesia, and dystoniaPascal Sienaert, Peter van Harten, Didi Rhebergen
Journal of Forensic Sciences|March 24, 2020
Overlooking Feigning Behavior May Result in Potential Harmful Treatment Interventions: Two Case Reports of Undetected MalingeringDouwe van der Heide, Irena Boskovic, Peter van Harten, et al.
Journal of Clinical Psychopharmacology|December 27, 2011
All-cause mortality and medication risk factors in schizophrenia: a prospective cohort studyDiederik Tenback, Bram Pijl, Hugo Smeets, et al.
International Journal of Clinical and Health Psychology : IJCHP|January 16, 2024
A Network Model of Health-Related Changes after a Lifestyle-Enhancing Treatment in Patients with Severe Mental Illness: the MULTI Study VILydia Pieters, Tessa Blanken, Kirsten van Lunteren, et al.
Schizophrenia Research|April 19, 2024
The association between alterations in motor and cognitive dimensions of schizophrenia-spectrum disorders: A systematic reviewBernardo Melo Moura, Luís Madeira, P Roberto Bakker, et al.
Frontiers in Psychiatry|September 13, 2021
Drug-Induced Stuttering: Occurrence and Possible PathwaysCorine Ekhart, Florence van Hunsel, Peter van Harten, et al.
Neuropsychological Rehabilitation|May 12, 2021
Efficacy and safety of amantadine as a treatment for apathy after brain injury: Two single-case experimental design studiesPeggy Spauwen, Bert Ter Mors, Peter van Harten, et al.
Perspectives in Psychiatric Care|April 17, 2014
Effects and feasibility of the "traffic light method for somatic screening and lifestyle" in patients with severe mental illness: a pilot studyBerno van Meijel, Sonja van Hamersveld, Ronald van Gool, et al.
Psychiatry Research|April 30, 2017
Accelerometer-measured sedentary behaviour and physical activity of inpatients with severe mental illnessFrank Kruisdijk, Jeroen Deenik, Diederik Tenback, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
CNS Drugs|February 11, 2018
Tardive Dyskinesia Associated with Atypical Antipsychotics: Prevalence, Mechanisms and Management StrategiesKatharina Stegmayer, Sebastian Walther, Peter van Harten
Handbook of Clinical Neurology|November 16, 2019
The psychopharmacology of catatonia, neuroleptic malignant syndrome, akathisia, tardive dyskinesia, and dystoniaPascal Sienaert, Peter van Harten, Didi Rhebergen
Journal of Forensic Sciences|March 24, 2020
Overlooking Feigning Behavior May Result in Potential Harmful Treatment Interventions: Two Case Reports of Undetected MalingeringDouwe van der Heide, Irena Boskovic, Peter van Harten, et al.
Journal of Clinical Psychopharmacology|December 27, 2011
All-cause mortality and medication risk factors in schizophrenia: a prospective cohort studyDiederik Tenback, Bram Pijl, Hugo Smeets, et al.
International Journal of Clinical and Health Psychology : IJCHP|January 16, 2024
A Network Model of Health-Related Changes after a Lifestyle-Enhancing Treatment in Patients with Severe Mental Illness: the MULTI Study VILydia Pieters, Tessa Blanken, Kirsten van Lunteren, et al.
Schizophrenia Research|April 19, 2024
The association between alterations in motor and cognitive dimensions of schizophrenia-spectrum disorders: A systematic reviewBernardo Melo Moura, Luís Madeira, P Roberto Bakker, et al.
Frontiers in Psychiatry|September 13, 2021
Drug-Induced Stuttering: Occurrence and Possible PathwaysCorine Ekhart, Florence van Hunsel, Peter van Harten, et al.
Neuropsychological Rehabilitation|May 12, 2021
Efficacy and safety of amantadine as a treatment for apathy after brain injury: Two single-case experimental design studiesPeggy Spauwen, Bert Ter Mors, Peter van Harten, et al.
Perspectives in Psychiatric Care|April 17, 2014
Effects and feasibility of the "traffic light method for somatic screening and lifestyle" in patients with severe mental illness: a pilot studyBerno van Meijel, Sonja van Hamersveld, Ronald van Gool, et al.
Psychiatry Research|April 30, 2017
Accelerometer-measured sedentary behaviour and physical activity of inpatients with severe mental illnessFrank Kruisdijk, Jeroen Deenik, Diederik Tenback, et al.
Pageof 2